Skip to Main Content

Paper Details

Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.
Clin Cancer Res
2
2022
Author NameAffiliation
Manish A ShahWeill Cornell Medicine/New York-Presbyterian Hospital
  • 1 - 1

Datasets

Release 1.2